Who can and cannot get weight-loss drugs

Drugs used for weight loss like Wegovy, Ozempic and Mounjaro are nearly everywhere in popular culture, but many patients struggling with obesity are still finding them hard to get. On today's show, what's slowing access to these drugs despite their long-term benefits for the economy and patients, and how social conditioning around obesity and excess weight clouds the conversation. Related Episodes:New drugs. Cheaper drugs. Why not both? (Apple / Spotify) For sponsor-free episodes of The Indicator from Planet Money, subscribe to Planet Money+ via Apple Podcasts or at plus.npr.org. Music by Drop Electric. Find us: TikTok, Instagram, Facebook, Newsletter.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

Om Podcasten

A little show about big ideas. From the people who make Planet Money, The Indicator helps you make sense of what's happening today. It's a quick hit of insight into work, business, the economy, and everything else. Listen weekday afternoons.Try Planet Money+! a new way to support the show you love, get a sponsor-free feed of the podcast, *and* get access to bonus content. You'll also get access to The Indicator and Planet Money Summer School, both without interruptions. sign up at plus.npr.org/planetmoney